Literature DB >> 24494150

Prevalence of Human Immunodeficiency Virus Infection among Injection Drug Users Released from Jail.

Ali Reza Moradi1, Abbas Emdadi2, Bahram Soori3, Ehsan Mostafavi4.   

Abstract

BACKGROUND: Injecting drug users (IDUs) and prisoners are considered to be highly vulnerable to human immunodeficiency virus (HIV) infection in Iran. This study was carried out to determine the prevalence of HIV infection among IDUs released from jail in Bahar (Hamadan, Iran).
METHODS: In a cross-sectional study, 118 IDUs who were prisoners during 2001-07 were evaluated. Their demographic and personal characteristics were assessed by a questionnaire. In order to determine HIV-positive individuals, blood samples were obtained from the participants and tested by enzyme-linked immunosorbent assay and Western blot technique.
FINDINGS: Overall, 20.3% of the subjects had used non-sterile injecting equipment during their imprisonment. The prevalence of HIV infection among the studied population was 4.2%.
CONCLUSION: As the prevalence of HIV among IDUs released from jail is high, it is necessary for prison authorities to take measures against the increase in the prevalence of HIV among this group.

Entities:  

Keywords:  Acquired immunodeficiency syndrome; Bahar (Iran); Human immunodeficiency virus; Injection drug users

Year:  2012        PMID: 24494150      PMCID: PMC3905540     

Source DB:  PubMed          Journal:  Addict Health        ISSN: 2008-4633


  6 in total

1.  High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran.

Authors:  Saman Zamani; Masahiro Kihara; Mohammad M Gouya; Mohsen Vazirian; Bijan Nassirimanesh; Masako Ono-Kihara; Shahrzad Mortazavi Ravari; Afshin Safaie; Seiichi Ichikawa
Journal:  J Acquir Immune Defic Syndr       Date:  2006-07       Impact factor: 3.731

Review 2.  Prison-based syringe exchange programmes: a review of international research and development.

Authors:  Kate Dolan; Scott Rutter; Alex D Wodak
Journal:  Addiction       Date:  2003-02       Impact factor: 6.526

3.  Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Authors:  Steven Petrar; Thomas Kerr; Mark W Tyndall; Ruth Zhang; Julio S G Montaner; Evan Wood
Journal:  Addict Behav       Date:  2006-08-22       Impact factor: 3.913

Review 4.  Regional HIV knowledge hubs: a new approach by the health sector to transform knowledge into practice.

Authors:  Ehsan Mostafavi; Aliakbar Haghdoost; Ali Mirzazadeh; Gabriele Riedner; Peter Weis; Kristina Kloss; Farzaneh Zolala
Journal:  Health Promot Int       Date:  2012-09-03       Impact factor: 2.483

5.  Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.

Authors:  Saman Zamani; Ramin Radfar; Pardis Nematollahi; Reza Fadaie; Marjan Meshkati; Shahrzad Mortazavi; Abbas Sedaghat; Masako Ono-Kihara; Masahiro Kihara
Journal:  Int J Drug Policy       Date:  2010-05-18

6.  Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.

Authors:  S Babudieri; B Longo; L Sarmati; G Starnini; L Dori; B Suligoi; S Carbonara; R Monarca; G Quercia; G Florenzano; S Novati; A Sardu; V Iovinella; A Casti; A Romano; I Uccella; I Maida; B Brunetti; M S Mura; M Andreoni; G Rezza
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

  6 in total
  3 in total

1.  Epidemiologic characteristics of HIV-positive patients referring to behavioral diseases consultation center in Shiraz, Iran.

Authors:  Yousef Alimohamadi; Hamidreza Tabatabaee; Parvin AfsarKazerooni; Sajad Vahedi; Meysam Enaami; Abedin Teimourizad
Journal:  Med J Islam Repub Iran       Date:  2014-12-14

Review 2.  Emerging and re-emerging infectious diseases in Iran.

Authors:  Najmeh Parhizgari; Mohammad Mehdi Gouya; Ehsan Mostafavi
Journal:  Iran J Microbiol       Date:  2017-06

Review 3.  Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.

Authors:  Shah Jahan Shayan; Rajab Nazari; Frank Kiwanuka
Journal:  Harm Reduct J       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.